Presentation Theater

New this year at TCT is the Presentation Theater, located in the Exhibit Hall. This theater will include the Case Consultation session, the Electronic Health Records session, the Hypothetical Case Presentation session, and sessions from industry concerning the latest developments in cardiovascular devices. Presentation Theater sessions are non-CME.

Tuesday, September 22

Room 121, 12:00 pm-1:00 pm

Within-the-Tunnel PFO Closure: Refining Your Approach and Treating the Tunnel Using the Coherex FlatStent™ EF PFO Closure System

Sponsored by Coherex, Inc.
Lunch will be provided.

The Coherex FlatStent™ EF PFO Closure System is the first within-the-tunnel device to receive a CE mark. This session will present an overview of the device, how it is used, up-to-date clinical results, and tips and tricks on sizing and device selection. The FlatStent™ EF is designed with the intent to minimize exposed surface area, minimize septal distortion, reduce the risk of tissue erosion, and reduce the risk of air embolism by incorporating rapid exchange delivery.

To register, please contact Kathleen Carter at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or 801-433-9900.

Wednesday, September 23

Exhibit Hall, 11:00 am-4:15 pm

11:00 am-12:00 pm

Case Consultation Session

Physicians were invited to submit their challenging cases to receive consultation from TCT Faculty on how to treat their patients.
Moderator: Giora Weisz
Discussants: Mark W. Connolly, Eulogio Garcia, Igor F. Palacios

12:30 pm-1:30 pm

Key Opinion Leader Discussion of the Important Role Low-Osmolar, Ionic Contrast Media Can Play in Improving Patient Outcomes

Sponsored by Guerbet LLC
Lunch will be provided.

This Key Opinion Leader Lunch Program will be presenting data on the role of low-osmolar, ionic contrast media including insights from an endovascular perspective as well as a discussion of interventional cardiac procedures.
Moderators: Samuel M. Butman, Bhagat K. Reddy

To register, please contact Melissa Buchanan at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or 877-729-6679.

2:00 pm-3:00 pm

The Future of Interventional Medicine: What Will Interventional Cardiologists Be Doing in Five Years?

Sponsored by Medtronic, Inc.
Chair: Mark A. Turco
Speakers: Jeffrey J. Popma, Krishna J. Rocha-Singh, James P. Zidar

Expert panel and audience discussion on how continued innovation will change the face of interventional medicine, training needs, and practice management. The goal of this session is to provide attendees with important insights into the adjustments they should be considering for their future practices.

To register, please visit www.seeuthere.com/FutureInterventionalMedicine.

3:15 pm-4:15 pm

A Satirical Case Presentation from the BBC

Moderators: David Hildick-Smith, Martyn R. Thomas

Thursday, September 24

Exhibit Hall, 9:30 am-4:15 pm

9:30 am-12:00 pm

Electronic Health Records: What You Need to Know

Leading experts will discuss the latest developments in Electronic Health Records (EHR) and its relevance to health care reform. The session will include solutions for integrated health systems, with the pros and cons.

9:30 am	The NewYork-Presbyterian Experience: EHR Solutions for Integrated Health Systems Aurelia G. Boyer
9:55 am	EHR Solutions: The Private Practice Setting TBA
10:20 am	ARRA, Certification, Meaningful Use, Interoperability: How Will This Affect Me? James E. Tcheng, Professor of Medicine and Medical Knowledge Architect, Duke University Health System
10:45 am	Personal Health Records: Putting the "Me" in "Medicine" David Feinberg, Grad Conn
11:10 am	Roundtable Discussion
11:35 am	"CVIS": Integrated Cardiovascular Information Systems: The Way of the Future? Jeremy Bikman

12:30 pm-1:30 pm

A Modern Day Approach to Vascular Advancement

Sponsored by Abbott Vascular
Lunch will be provided.

The SPIRIT Trials have consistently shown strong results of XIENCE V compared to TAXUS. Join Chuck Simonton, MD, Abbott Vascular Chief Medical Officer, and two physician speakers who will debate the results of the latest XIENCE V SPIRIT data and their impact on the selection of DES for patients.

To register, please contact Rachelle Bell at This e-mail address is being protected from spambots. You need JavaScript enabled to view it .

2:00 pm-3:00 pm

A Newly Developed Antiplatelet Therapy for Patients with Acute Coronary Syndrome Managed with PCI

Sponsored by Daiichi Sankyo, Inc. and Lilly USA, LLC

This presentation focuses on a new antiplatelet therapy for patients with acute coronary syndrome managed with PCI.

 

3:15 pm-4:15 pm

The AZNET Hypothetical Case Presentation

Moderator: Ian T. Meredith